GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Foods International Co Ltd (TSE:2929) » Definitions » Capex-to-Revenue

Pharma Foods International Co (TSE:2929) Capex-to-Revenue : 0.00 (As of Jan. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Pharma Foods International Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Pharma Foods International Co's Capital Expenditure for the three months ended in Jan. 2024 was 円0.00 Mil. Its Revenue for the three months ended in Jan. 2024 was 円15,510.00 Mil.

Hence, Pharma Foods International Co's Capex-to-Revenue for the three months ended in Jan. 2024 was 0.00.


Pharma Foods International Co Capex-to-Revenue Historical Data

The historical data trend for Pharma Foods International Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Foods International Co Capex-to-Revenue Chart

Pharma Foods International Co Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.06 - 0.01 0.01

Pharma Foods International Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pharma Foods International Co's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Foods International Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Foods International Co's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Foods International Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Pharma Foods International Co's Capex-to-Revenue falls into.



Pharma Foods International Co Capex-to-Revenue Calculation

Pharma Foods International Co's Capex-to-Revenue for the fiscal year that ended in Jul. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-405) / 68572
=0.01

Pharma Foods International Co's Capex-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 15510
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Foods International Co  (TSE:2929) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Pharma Foods International Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Pharma Foods International Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Foods International Co (TSE:2929) Business Description

Traded in Other Exchanges
N/A
Address
1-49 Ohara Kyoto imperial tomb Saikyo-ku, Kyoto, JPN, 615-8245
Pharma Foods International Co Ltd is engaged in the development and sales of functional food materials.

Pharma Foods International Co (TSE:2929) Headlines

No Headlines